MARKET

DERM

DERM

Journey Medical Corp
NASDAQ
7.71
-0.21
-2.65%
After Hours: 7.71 0 0.00% 16:41 12/29 EST
OPEN
7.94
PREV CLOSE
7.92
HIGH
8.01
LOW
7.69
VOLUME
83.17K
TURNOVER
--
52 WEEK HIGH
9.40
52 WEEK LOW
3.535
MARKET CAP
209.22M
P/E (TTM)
-21.1523
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DERM last week (1222-1226)?
Weekly Report · 19h ago
Weekly Report: what happened at DERM last week (1215-1219)?
Weekly Report · 12/22 10:20
Weekly Report: what happened at DERM last week (1208-1212)?
Weekly Report · 12/15 10:27
Journey Medical announces results from Phase 1 trial of DFD-29
TipRanks · 12/10 13:50
Journey Medical Reports Emrosi Shows No Impact on Microbiome in Phase 1 Trial
Reuters · 12/10 13:30
JOURNEY MEDICAL CORPORATION ANNOUNCES PUBLICATION OF CLINICAL TRIAL RESULTS ASSESSING THE IMPACT OF EMROSI™ (DFD-29) ON MICROBIAL FLORA OF HEALTHY ADULTS IN THE JOURNAL OF DRUGS IN DERMATOLOGY
Reuters · 12/10 13:30
Weekly Report: what happened at DERM last week (1201-1205)?
Weekly Report · 12/08 10:26
Weekly Report: what happened at DERM last week (1124-1128)?
Weekly Report · 12/01 10:21
More
About DERM
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.

Webull offers Journey Medical Corp stock information, including NASDAQ: DERM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DERM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DERM stock methods without spending real money on the virtual paper trading platform.